The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–295 of 295
Characterization of two receptors for TRAIL1
Schneider, P., Bodmer, J.-L., Thome, M., Hofmann, K., Holler, N., & Tschopp, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01231-3 · Cited by 290
Jäättelä, M., Benedict, M., Tewari, M., Ja, S., & Dixit, V. (1995) · PubMed · Cited by 289
Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition.
Kayalar, C., Ord, T., Testa, M. P., Zhong, L. T., & Bredesen, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2234 · Cited by 288
Induction of DNA strand breaks associated with apoptosis during treatment of leukemias.
Gorczyca, W., Bigman, K., Mittelman, A., Ahmed, T., GONG, J., Melamed, M. R., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 285
Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
Graninger, W. B., Seto, M., Boutain, B., Goldman, P., & Korsmeyer, S. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113235 · Cited by 281
Sensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281
Cloning of TRAP, a ligand for CD40 on human T cells
Graf, D., Korthäuer, U., Mages, H. W., Senger, G., & Kroczek, R. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221226 · Cited by 280
Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Möller, P., & Krammer, P. H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.10.3166 · Cited by 278
Self-citationActivation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
Herr, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6200 · Cited by 278
Munday, N. A., Vaillancourt, J. P., Ali, A., Casano, F. J., Miller, D. K., Molineaux, S. M., Yamin, T.-T., Yu, V. L., & Nicholson, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15870 · Cited by 277
Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., VandenBos, T., Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90133-b · Cited by 277
Godfrey, W. R., Fagnoni, F. F., Harara, M. A., Buck, D., & Engleman, E. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.757 · Cited by 271
Brancolini, C., Benedetti, M., & Schneider, C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00202.x · Cited by 266
Bodmer, J.-L., Burns, K., Schneider, P., Hofmann, K., Steiner, V., Thome, M., Bornand, T., Hahne, M., Schröter, M., Becker, K., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80244-7 · Cited by 264
Kamens, J., Paskind, M., Hugunin, M., Talanian, R. V., Allen, H., Banach, D., Bump, N., Hackett, M., Johnston, C. G., Li, P., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15250 · Cited by 262
Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences
Dembic, Z., Loetscher, H., Gubler, U., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., & Lesslauer, W. (1990) · Cytokine · doi:10.1016/1043-4666(90)90022-l · Cited by 261
Cook, W. D., Metcalf, D., Nicola, N. A., Burgess, A. W., & Walker, F. (1985) · Cell · doi:10.1016/s0092-8674(85)80048-9 · Cited by 260
Vincenz, C., & Dixit, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6578 · Cited by 256
Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D., & Ashkenazi, A. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70791-4 · Cited by 250
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
Zimmerman, C., Brduscha-Riem, K., Blaser, C., Zinkernagel, R. M., & Pircher, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1367 · Cited by 250
Mittl, P. R. E., Di Marco, S., Krebs, J. F., Bai, X., Karanewsky, D. S., Priestle, J. P., Tomaselli, K. J., & Grütter, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6539 · Cited by 250
Gene transfer of Fas ligand induces tumor regression in vivo
Arai, H., Gordon, D., Nabel, E. G., & Nabel, G. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13862 · Cited by 248
Gottschalk, A. R., Boise, L. H., Thompson, C. B., & Quintáns, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7350 · Cited by 248
Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis.
Jänicke, R. U., Walker, P. A., Lin, X. Y., & Porter, A. G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01089.x · Cited by 247
Actin cleavage by CPP-32/apopain during the development of apoptosis
Mashima, T., Naito, M., Noguchi, K., Miller, D. K., Nicholson, D. W., & Tsuruo, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200919 · Cited by 245
Neamati, N., Fernandez, A., Wright, S., Kiefer, J., & McConkey, D. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3788 · Cited by 237
Wang, S., Miura, M., Jung, Y.-K., Zhu, H., Gagliardini, V., Shi, L., Greenberg, A. H., & Yuan, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20580 · Cited by 236
Han, D. K. M., Chaudhary, P. M., Wright, M. E., Friedman, C., Trask, B. J., Riedel, R. T., Baskin, D. G., Schwartz, S. M., & Hood, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11333 · Cited by 235
Brojatsch, J., Naughton, J., Rolls, M. M., Zingler, K., & Young, J. A. T. (1996) · Cell · doi:10.1016/s0092-8674(00)81992-3 · Cited by 234
Lippke, J. A., Gu, Y., Sarnecki, C., Caron, P. R., & Su, M. S.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1825 · Cited by 225
The Role of APO‐1‐Mediated Apoptosis in the Immune System
Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., et al. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00889.x · Cited by 225
Self-citationTumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway.
Miura, M., Friedlander, R. M., & Yuan, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8318 · Cited by 222
Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases
Mariani, S. M., Matiba, B., Bäumler, C., & Krammer, P. H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250828 · Cited by 217
Self-citationBcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Núñez, G., & Castle, V. P. (1995) · PubMed · Cited by 214
D4-GDI, a Substrate of CPP32, Is Proteolyzed during Fas-induced Apoptosis
Na, S., Chuang, T.-H., Cunningham, A., Turi, T. G., Hanke, J. H., Bokoch, G. M., & Danley, D. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11209 · Cited by 211
Screaton, G. R., Xu, X.-N., Olsen, A. L., Cowper, A. E., Tan, R., McMichael, A. J., & Bell, J. I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4615 · Cited by 211
PITSLRE protein kinase activity is associated with apoptosis
Lahti, J. M., Xiang, J., Heath, L. S., Campana, D., & Kidd, V. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.1 · Cited by 210
Cryns, V. L., Bergeron, L., Zhu, H., Li, H., & Yuan, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31277 · Cited by 209
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Wissing, D., Mouritzen, H., Egeblad, M., Poirier, G. G., & Jäättelä, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5073 · Cited by 207
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
Friesen, C., Fulda, S., & Debatin, K.-M. (1997) · Leukemia · doi:10.1038/sj.leu.2400827 · Cited by 207
Bcl-2 and Bcl-2-Related Proteins in Apoptosis Regulation
Boise, L. H., Gottschalk, A. R., Quintáns, J., & Thompson, C. B. (1995) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-79437-7_8 · Cited by 206
Mashima, T., Naito, M., Fujita, N., Noguchi, K., & Tsuruo, T. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2894 · Cited by 206
An, B., & Dou, Q. P. (1996) · PubMed · Cited by 205
Mariani, S. M., & Krammer, P. H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<973::aid-immu973>3.0.co;2-t · Cited by 205
Self-citationFas-Mediated Apoptosis in Primary Cultured Mouse Hepatocytes
Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., & Nagata, S. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1349 · Cited by 199
Neilan, J. G., Lu, Z., Afonso, C. L., Kutish, G. F., Sussman, M. D., & Rock, D. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4391-4394.1993 · Cited by 195
Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
Sumantran, V. N., Ealovega, M. W., Núñez, G., Clarke, M. F., & Wicha, M. S. (1995) · PubMed · Cited by 195
A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis.
Chu, K., Niu, X., & Williams, L. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11894 · Cited by 193
Molecular Ordering of Apoptotic Mammalian CED-3/ICE-like Proteases
Orth, K., O'Rourke, K., Salvesen, G. S., & Dixit, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.20977 · Cited by 191
Los, M., Herr, I., Friesen, C., Fulda, S., Schulze-Osthoff, K., & Debatin, K.-M. (1997) · Blood · doi:10.1182/blood.v90.8.3118 · Cited by 190
The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.
Eck, M. J., Ultsch, M., Rinderknecht, E., de Vos, A. M., & Sprang, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45849-8 · Cited by 187
Leucocyte typing VI : white cell differentiation antigens
Kishimoto, T. (1998) · Cited by 187
ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5
Hsu, H., Solovyev, I., Colombero, A., Elliott, R., Kelley, M., & Boyle, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13471 · Cited by 180
Oncogenic potential of bcl-2 demonstrated by gene transfer
Reed, J. C., Cuddy, M., Slabiak, T., Croce, C. M., & Nowell, P. C. (1988) · Nature · doi:10.1038/336259a0 · Cited by 180
Tewari, M., Beidler, D. R., & Dixit, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18738 · Cited by 178
Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma
Memon, S. A., Moreno, M. B., Petrak, D., & Zacharchuk, C. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.4644 · Cited by 172
Vaux, D. L., Aguila, H. L., & Weissman, I. L. (1992) · International Immunology · doi:10.1093/intimm/4.7.821 · Cited by 164
Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal
Broome, H. E., Dargan, C. M., Krajewski, S., & Reed, J. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2311 · Cited by 163
Apoptosis by a cytosolic extract from Fas-activated cells.
Enari, M., Hase, A., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00204.x · Cited by 162
Cleavage of FLICE (caspase‐8) by granzyme B during cytotoxic T lymphocyte‐induced apoptosis
Medema, J. P., Toes, R. E. M., Scaffidi, C., Zheng, T. S., Flavell, R. A., Melief, C. J. M., Peter, M. E., Offringa, R., & Krammer, P. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271250 · Cited by 162
Self-citationLethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes
Tanaka, M., Suda, T., Yatomi, T., Nakamura, N., & Nagata, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2303 · Cited by 159
Kolesnick, R. N., Haimovitz‐Friedman, A., & FUKS, Z. Y. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-063 · Cited by 155
Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle.
Bunnell, B. A., Heath, L. S., Adams, D. E., Lahti, J. M., & Kidd, V. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7467 · Cited by 154
Gu, Y., Sarnecki, C., Aldape, R. A., Livingston, D. J., & Su, M. S. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18715 · Cited by 152
Wang, X., Pai, J., Wiedenfeld, E. A., Medina, J. C., Slaughter, C. A., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18044 · Cited by 149
Evidence for CPP32 Activation in the Absence of Apoptosis during T Lymphocyte Stimulation
Miossec, C., Collard‐Dutilleul, V., Fassy, F., & Diu‐Hercend, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13459 · Cited by 148
Beyaert, R., Kidd, V. J., Cornelis, S., de Craen, M. V., Denecker, G., Lahti, J. M., Gururajan, R., Vandenabeele, P., & Fiers, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11694 · Cited by 145
Choi, M. S. K., Boise, L., GOTTSCHALK, A. R., Quintáns, J., Thompson, C. B., & Klaus, G. G. B. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250533 · Cited by 144
Mongkolsapaya, J., Cowper, A., Xu, X., Morris, G. M., McMichael, A. J., Bell, J. I., & Screaton, G. R. (1998) · PubMed · Cited by 140
Knipping, E., Debatin, K., Stricker, K., Heilig, B., Eder, A. M., & Krammer, P. (1995) · Blood · doi:10.1182/blood.v85.6.1562.bloodjournal8561562 · Cited by 140
Self-citationProgrammed cell death by bcl‐2‐dependent and independent mechanisms in B lymphoma cells.
Cuende, E., Alés-Martínez, J. E., Ding, L.-Y., González‐García, M., Martínez, C., & Núñez, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05799.x · Cited by 139
Waterhouse, N. J., Kumar, S., Song, Q., Strike, P., Sparrow, L. G., Dreyfuss, G., Alnemri, E. S., Litwack, G., Lavin, M. F., & Watters, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29335 · Cited by 126
Bcl-xL Acts Downstream of Caspase-8 Activation by the CD95 Death-inducing Signaling Complex
Medema, J. P., Scaffidi, C., Krammer, P. H., & Peter, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3388 · Cited by 122
Self-citationInhibition of Apoptosis in T Cells Expressing Human T Cell Leukemia Virus Type I Tax
Copeland, K. F. T., Haaksma, A. G. M., Goudsmit, J., Krammer, P. H., & Heeney, J. L. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1259 · Cited by 116
Self-citationMongkolsapaya, J., Cowper, A. E., Xu, X., Morris, G. M., McMichael, A. J., Bell, J. I., & Screaton, G. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.3 · Cited by 116
Suda, T., Tanaka, M., Miwa, K., & Nagata, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3918 · Cited by 110
Vanhaesebroeck, B., Reed, J. C., VALCK, D. D., et al. (1993) · PubMed · Cited by 106
Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity.
Chiu, V. K., Walsh, C. M., Liu, C.-C., Reed, J. C., & Clark, W. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2023 · Cited by 105
Peter, M. E., Scaffidi, C., Medema, J. P., Kischkel, F. C., & Krammer, P. H. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69184-6_3 · Cited by 102
Self-citationIdentification of the MDM2 Oncoprotein as a Substrate for CPP32-like Apoptotic Proteases
Erhardt, P., Tomaselli, K. J., & Cooper, G. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15049 · Cited by 100
PAI, J.-A., Brown, M. S., & Goldstein, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5437 · Cited by 81
Identification of a Cysteine Protease Closely Related to Interleukin‐1β‐Converting Enzyme
Faucheu, C., Blanchet, A., Collard‐Dutilleul, V., Lalanne, J., & Diu‐Hercend, A. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.t01-1-00207.x · Cited by 76
Cuppen, E. P. J. G., Nagata, S., Wieringa, B., & Hendriks, W. J. A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30215 · Cited by 68
Fas‐mediated Cytotoxicity ‐ A New Immunoregulatory and Pathogenic Function of Thl CD4+ T Cells
YAGITA, H., Hanabuchi, S., ASANO, Y., TAMURA, T., NARIUCHI, H., & Okumura, K. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00691.x · Cited by 64
Cytotoxic Drugs, Programmed Cell Death, and the Immune System: Defining New Roles in an Old Play
Debatin, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.750 · Cited by 59
CD95(APO-1/Fas)-Mediated Apoptosis in Normal and Malignant Liver, Colon, and Hematopoietic Cells
Krammer, P. H., Galle, P. R., Möller, P., & Debatin, K. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60744-7 · Cited by 54
Self-citationAssociation of Human Fas (CD95) with a Ubiquitin-conjugating Enzyme (UBC-FAP)
Wright, D. A., Futcher, B., Ghosh, P., & Geha, R. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31037 · Cited by 54
Baens, M., Chaffanet, M., Cassiman, J., BERGHE, H. V. D., & Marynen, P. (1993) · Genomics · doi:10.1006/geno.1993.1161 · Cited by 50
The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19
Lichter, P., Walczak, H., Weitz, S., Behrmann, I., & Krammer, P. H. (1992) · Genomics · doi:10.1016/s0888-7543(05)80302-7 · Cited by 48
Self-citationDanley, D. E., Chuang, T., & Bokoch, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.500 · Cited by 46
APO‐1(CD95)‐mediated apoptosis in Jurkat cells does not involve src kinases or CD45
Schraven, B. L., & Peter, M. E. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00720-t · Cited by 42
Smith, D. J., McGuire, M. J., Mj, T., & Thiele, D. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.163 · Cited by 41
Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones
Anel, A., Simon, A. K., Auphan‐Anezin, N., Buferne, M., Boyer, C., Golstein, P., & Schmitt‐Verhulst, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251227 · Cited by 41
Krammer, P. H. (1997) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400252 · Cited by 36
Self-citation
Cited by
Role of reactive oxygen species (ROS) in apoptosis induction
Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000) · Apoptosis · doi:10.1023/a:1009616228304 · Cited by 2,774
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Self-citationCD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
Self-citationMore than one way to die: apoptosis, necrosis and reactive oxygen damage
Fiers, W., Beyaert, R., Declercq, W., & Vandenabeele, P. (1999) · Oncogene · doi:10.1038/sj.onc.1203249 · Cited by 864
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
Metadata
- Authors
- Krammer, P. H.
- Venue
- Advances in Immunology
- Publisher
- Elsevier
- Published
- 1998
- Volume
- 71
- Pages
- 163-210
- ISSN
- 0065-2776 (ISSN-L)
- OpenAlex
- W1667997885
- Cited by
- 394
- References
- 295
- FWCI
- 47.49
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.